Indefinite Delivery Contract SPE2DR25D9980

The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999, held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract was awarded by the Defense Logistics Agency (DLA) under the SPE2DB program and covers a 10-year period through November 2026.

The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract encompasses various product categories such as injections, tablets, creams, auto-injectors, and specialty medications, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain and providing direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) healthcare sites. The original solicitation was an unrestricted, fully competitive acquisition with the intent to make multiple awards for separate regions, with DMS Pharmaceutical Group securing a single-award IDC across all regions.